Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Janssen looks to expand Darzalex in Europe

Janssen looks to expand Darzalex in Europe

Additionally, both MorphoSys and Takeda each have their own myeloma drugs in mid-stage testing and Bristol-Myers Squibb and AbbVie are hoping that SLAMF7 targeting Empliciti, in combination with Revlimid,

BMS defends Celgene buyout ahead of shareholder vote

BMS defends Celgene buyout ahead of shareholder vote BMS battles for hearts and minds before shareholder vote. Bristol-Myers Squibb is looking to convince investors that its $74bn takeover of Celgene is a sound move, ahead of a key

CHMP recommends new Keytruda dosing schedule

CHMP recommends new Keytruda dosing schedule A decision is expected from the EMA during the second quarter of 2019, and the decision could put even more pressure on its main rival Opdivo, Bristol-Myers Squibb’s

AZ to address Imfinzi setback, but sees potential with Tagrisso

AZ to address Imfinzi setback, but sees potential with Tagrisso Bristol-Myers Squibb also followed a similar pattern with its PD-1 inhibitor Opdivo, after it failed in first-line NSCLC, but paired that drug up with its CTLA4 inhibitor Yervoy.

BMS trades blows with investor on Celgene deal merits

BMS trades blows with investor on Celgene deal merits Activist investors claim Celgene’s pipeline is “extremely risky”. Bristol-Myers Squibb has issued a defence of its proposed $74bn merger, with Celgene as an activist fund steps up its attempts

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics